131 related articles for article (PubMed ID: 2781890)
41. Oral contraceptives and venous thromboembolism.
Dunn N
BMJ; 2009 Aug; 339():b3164. PubMed ID: 19679617
[No Abstract] [Full Text] [Related]
42. [Hormonal contraception and thromboembolic disease. I. Epidemiologic data].
Paseka J; Unzeitig V
Ceska Gynekol; 1997 Apr; 62(2):75-8. PubMed ID: 9296797
[No Abstract] [Full Text] [Related]
43. [Lamb to the slaughter].
Merviel P
Gynecol Obstet Fertil; 2013 Apr; 41(4):211-2. PubMed ID: 23562417
[No Abstract] [Full Text] [Related]
44. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
45. [Current oral hormonal contraception].
Terdzgomanov R
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():43-5. PubMed ID: 19504707
[No Abstract] [Full Text] [Related]
46. Hormones and pregnancy: thromboembolic risks for women.
Kujovich JL
Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
[TBL] [Abstract][Full Text] [Related]
47. Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide?
Vandenbroucke JP; Hazes JM; Dijkmans BA; Cats A
Br J Rheumatol; 1989; 28 Suppl 1():1-3; discussion 18-23. PubMed ID: 2819340
[No Abstract] [Full Text] [Related]
48. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
Beller F; Theiss W
Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
[TBL] [Abstract][Full Text] [Related]
49. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
Bershteĭn LM
Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
[No Abstract] [Full Text] [Related]
50. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
51. Re: "Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease".
Thorogood M; Yudkin P
Am J Epidemiol; 1991 Nov; 134(9):1009; author reply 1009-10. PubMed ID: 1951289
[No Abstract] [Full Text] [Related]
52. Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk.
Wilks JF
Ann Pharmacother; 2003 Jun; 37(6):912-6. PubMed ID: 12773085
[No Abstract] [Full Text] [Related]
53. [Benefits and risk of the modern combined hormonal contraception].
Fait T; Nouzová K; Sýkorová P; Fanta M; Vrablík M; Skrenková J
Cas Lek Cesk; 2005; 144(4):238-44. PubMed ID: 15945482
[TBL] [Abstract][Full Text] [Related]
54. Upper extremity deep vein thrombosis after suspension of progesterone-only oral treatment.
Lapecorella M; Orecchioni A; Dell'Orso L; Mariani G
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):513-7. PubMed ID: 17581329
[TBL] [Abstract][Full Text] [Related]
55. [Thromboembolic attacks in the central nervous system and P-pills].
Lidegaard O
Ugeskr Laeger; 1982 Sep; 144(38):2769-72. PubMed ID: 7157502
[TBL] [Abstract][Full Text] [Related]
56. [Liver tumors in women using oral hormonal contraceptives].
Rabe T; Feldmann K; Grunwald K; Runnebaum B
Zentralbl Gynakol; 1995; 117(3):153-6. PubMed ID: 7740850
[TBL] [Abstract][Full Text] [Related]
57. [Blood coagulation tests and oral contraceptives].
Scalettaris U; Bertolini C; Michelon C
Minerva Ginecol; 1987 May; 39(5):325-7. PubMed ID: 3627540
[No Abstract] [Full Text] [Related]
58. [Current developments in hormonal contraception].
Hamerlynck JV
Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2018-21. PubMed ID: 7177211
[TBL] [Abstract][Full Text] [Related]
59. [Hormonal contraceptives].
Carlotti N
Rev Prat; 2008 Jan; 58(1):21-8. PubMed ID: 18326358
[TBL] [Abstract][Full Text] [Related]
60. Oral contraception.
Bampton J
Aust Fam Physician; 1986 Jun; 15(6):763-6. PubMed ID: 3753327
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
